Answers are grounded in this paper and cite their sources.
To the Editor: Drug-induced hyperpigmentation is a common cause of an acquired increase in pigmentation.Belumosudil is an oral selective inhibitor of Rho-associated coiled-coil containing protein kinase (ROCK2) that is approved for the treatment of chronic graft-vs-host disease (GVHD).We describe a patient who developed diffuse skin bronzing 3 weeks after initiation of belumosudil treatment.A 64-year-old fair-skinned woman presented to the dermatology clinic with bronzing of the skin and dystrophic nails 3 weeks after starting belumosudil for treatment of chronic GVHD.Six months prior to presentation, the patient had received a bone marrow transplant for chronic lymphoid leukemia.She presented to dermatology 6 months after the transplant with a new-onset rash that was suspicious for GVHD.Physical examination revealed pruritic pink papules diffusely scattered on the legs and forearms (Figure 1).The patient declined biopsy at that time and later followed up with oncology.The
No takes yet. Share an insight, caveat, or question.
Melissa Cheng (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: